Download - WHOCC

QG03C
ESTROGENS
Plain estrogens and combinations should be classified in this group, except for
combinations with:
Androgens, which are classified in QG03E
Progestogens, which are classified in QG03F
Gonadotrophins, which are classified in QG03G
Hormonal contraceptives, which are classified in QG03A
Estrogens used only in neoplastic diseases, see QL02AA
QG03CA
Natural and semisynthetic estrogens, plain
Preparations which contain one or more natural or semisynthetic estrogen should be
classified in this group. Estradiol/polyestradiol are classified in the same 5th level
group. The same applies to estriol/polyestriol. Combinations with other substances
are classified in QG03CC.
Combinations of estradiol and ergometrine are classified in QG02AB53
ergometrine, combinations
Estropipate is classified in QG03CA07 - estrone.
QG03CB
Synthetic estrogens, plain
Preparations, which contain synthetic estrogens, only should be classified in this
group.
Combinations with other substances, see QG03CC.
QG03CC
Estrogens, combinations with other drugs
Preparations, which contain combinations of natural, semisynthetic or synthetic
estrogens and other substances, are classified in this group.
QG03CX
Other estrogens
Tibolone is classified in this group even though the chemical structure is different
from the other estrogens.
QG03D
PROGESTOGENS
Progestogens and combinations are classified in this group, except for combinations
with:
Androgens, which are classified in QG03E
Estrogens, which are classified in QG03F
Gonadotrophins, which are classified in QG03G
Hormonal contraceptives, which are classified in QG03A
Progestogens used only in neoplastic diseases, see QL02AB
76